Literature DB >> 8108408

Dual promoter activation by the human beta-globin locus control region.

E H Bresnick1, G Felsenfeld.   

Abstract

The human beta-globin locus control region (LCR) is necessary for high-level and position-independent expression of globin genes in erythroid cells. A variety of mechanisms have been proposed for the cis-activation of individual members of the beta-globin gene family by the LCR located 10-50 kilobases upstream. It is not known, however, whether a given LCR can activate all developmentally appropriate globin family members on its chromosome or whether, within a given chromosome, the LCR must be committed to activating only a single gene. We have devised an experiment to distinguish between these possibilities. This experiment takes advantage of the fact that if two genes in a cluster are transcriptionally active and their promoters, therefore, are in a conformation hypersensitive to nucleases, restriction enzymes that cleave the promoters will excise the intervening chromatin fragment. The Apa I sites on human fetal G gamma- and A gamma-globin gene promoters are accessible to cleavage in nuclei from the human erythroleukemia cell line K562, which expresses these genes, but not in HeLa cells. We find that Apa I digestion leads to excision in high yield of the fragment spanning these promoters, showing that a LCR element is capable of sharing its activating function among members of a gene cluster on a single chromosome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108408      PMCID: PMC43148          DOI: 10.1073/pnas.91.4.1314

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  Gene regulation by proteins acting nearby and at a distance.

Authors:  M Ptashne
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

2.  An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes.

Authors:  D Y Tuan; W B Solomon; I M London; D P Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  A developmentally stable chromatin structure in the human beta-globin gene cluster.

Authors:  W C Forrester; C Thompson; J T Elder; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  A dominant control region from the human beta-globin locus conferring integration site-independent gene expression.

Authors:  D Talbot; P Collis; M Antoniou; M Vidal; F Grosveld; D R Greaves
Journal:  Nature       Date:  1989-03-23       Impact factor: 49.962

5.  The "beta-like-globin" gene domain in human erythroid cells.

Authors:  D Tuan; W Solomon; Q Li; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 6.  The molecular genetics of human hemoglobin.

Authors:  F S Collins; S M Weissman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1984

7.  A single erythroid-specific DNase I super-hypersensitive site activates high levels of human beta-globin gene expression in transgenic mice.

Authors:  T M Ryan; R R Behringer; N C Martin; T M Townes; R D Palmiter; R L Brinster
Journal:  Genes Dev       Date:  1989-03       Impact factor: 11.361

8.  Evidence that the transcription factor USF is a component of the human beta-globin locus control region heteromeric protein complex.

Authors:  E H Bresnick; G Felsenfeld
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

9.  Inducible transcription of five globin genes in K562 human leukemia cells.

Authors:  A Dean; T J Ley; R K Humphries; M Fordis; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Position-independent, high-level expression of the human beta-globin gene in transgenic mice.

Authors:  F Grosveld; G B van Assendelft; D R Greaves; G Kollias
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

View more
  8 in total

1.  Chromatin interaction mechanism of transcriptional control in vivo.

Authors:  J Gribnau; E de Boer; T Trimborn; M Wijgerde; E Milot; F Grosveld; P Fraser
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

2.  Long-range disruption of gene expression by a selectable marker cassette.

Authors:  C T Pham; D M MacIvor; B A Hug; J W Heusel; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

3.  Synergism between hypersensitive sites confers long-range gene activation by the beta-globin locus control region.

Authors:  E H Bresnick; L Tze
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

4.  Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.

Authors:  Q H Gong; J C McDowell; A Dean
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  Discovering transcription factor regulatory targets using gene expression and binding data.

Authors:  Mark Maienschein-Cline; Jie Zhou; Kevin P White; Roger Sciammas; Aaron R Dinner
Journal:  Bioinformatics       Date:  2011-11-13       Impact factor: 6.937

6.  A targeted mutation at the T-cell receptor alpha/delta locus impairs T-cell development and reveals the presence of the nearby antiapoptosis gene Dad1.

Authors:  N A Hong; D Cado; J Mitchell; B D Ortiz; S N Hsieh; A Winoto
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

7.  Evidence for a bigenic chromatin subdomain in regulation of the fetal-to-adult hemoglobin switch.

Authors:  Hugues Beauchemin; Marie Trudel
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

Review 8.  A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation.

Authors:  E V Rothenberg; S B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.